A case of persistent skin rash and rhinitis with immune system dysregulation onboard the International Space Station

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):759-762.e8. doi: 10.1016/j.jaip.2015.12.021. Epub 2016 Mar 29.

Authors

Brian Crucian¹, Smith Johnston², Satish Mehta³, Raymond Stowe⁴, Peter Uchakin⁵, Heather Quiriarte³, Duane Pierson⁶, Mark L Laudenslager⁷, Clarence Sams²

Affiliations

¹ Biomedical Research and Environmental Sciences, NASA Johnson Space Center, Houston, Texas. Electronic address: brian.crucian-1@nasa.gov.
² Space and Clinical Operations, NASA Johnson Space Center, Houston, Texas.
³ Biomedical Research and Environmental Sciences, JES Tech, Houston, Texas.
⁴ Immunology Research, Microgen Laboratories, La Marque, Texas.
⁵ Department of Internal Medicine, Mercer University, Macon, Ga.
⁶ Biomedical Research and Environmental Sciences, NASA Johnson Space Center, Houston, Texas.
⁷ Behavioral Immunology and Endocrinology Laboratory, Denver Anschutz Medical Campus, University of Colorado, Denver, Colo.

PMID: 27036643
DOI: 10.1016/j.jaip.2015.12.021

No abstract available

Publication types

Case Reports
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Anti-Inflammatory Agents / therapeutic use*
Antifungal Agents / therapeutic use
Astronauts
Equipment Design
Exanthema / drug therapy
Exanthema / immunology*
Extravehicular Activity
Fluconazole / therapeutic use
Histamine Antagonists / therapeutic use
Humans
Hydrocortisone / therapeutic use
Immune System*
Methylprednisolone / therapeutic use
Naphthalenes / therapeutic use
Occupational Stress
Prednisone / therapeutic use
Rhinitis / drug therapy
Rhinitis / immunology*
Spacecraft*
Terbinafine
Triamcinolone Acetonide / therapeutic use

Substances

Anti-Inflammatory Agents
Antifungal Agents
Histamine Antagonists
Naphthalenes
Fluconazole
Triamcinolone Acetonide
Terbinafine
Prednisone
Hydrocortisone
Methylprednisolone